Two AI-based science assistants succeed with drug-retargeting tasks
Two AI-powered science assistants, Google's Co-Scientist and FutureHouse's Robin, have demonstrated success in drug repurposing tasks. These agentic systems scan vast amounts of biomedical literature to identify novel connections between research fields, aiming to suggest existing drugs for new diseases. The tools are designed to augment, not replace, human scientists by efficiently processing information that would be overwhelming for individuals. AI
IMPACT These AI assistants can accelerate drug discovery by efficiently processing scientific literature, potentially leading to faster identification of new treatments.